The subscription period in Diagonal Bio AB's ("Diagonal Bio" or the "Company") rights issue of units of initially approximately SEK 6.0 million ended on 6 February 2025 (the "Rights Issue"). The Right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback